Quality of Life in Greek Hemodialysis Patients Receiving Zemplar i.v (QualitiZe)
Phase of Trial: Phase IV
Latest Information Update: 25 Sep 2014
At a glance
- Drugs Paricalcitol (Primary)
- Indications Secondary hyperparathyroidism
- Focus Therapeutic Use
- Acronyms QUALITIZE
- Sponsors Abbott Laboratories; AbbVie
- 07 Jun 2017 Biomarkers information updated
- 01 Jun 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 14 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.